Inventor
APPALANENI RAJENDRA P
US9 patents
⚠️ This page may combine multiple inventors who share the name “APPALANENI RAJENDRA P”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ARRIEN PHARMACEUTICALS LLC
8 patentsUS9669028B2Jun 6, 2017
Substituted 5-(pyrazin-2-yl)-1H-pyrazolo [3, 4-B] pyridine and pyrazolo [3, 4-B] pyridine derivatives as protein kinase inhibitors
ARRIEN PHARMACEUTICALS LLC30 citations90
US9951062B2Apr 24, 2018
Substituted 1 H-pyrrolo [2, 3-b] pyridine and 1 H-pyrazolo [3, 4-b] pyridine derivatives as salt inducible kinase 2 (SIK2) inhibitors
ARRIEN PHARMACEUTICALS LLC3 citations69
US9890153B2Feb 13, 2018
Substituted 1H-pyrrolo [2, 3-b] pyridine and 1H-pyrazolo [3, 4-b] pyridine derivatives as salt inducible kinase 2 (SIK2) inhibitors
ARRIEN PHARMACEUTICALS LLC4 citations69
US9260426B2Feb 16, 2016
Substituted 1H-pyrrolo [2, 3-b] pyridine and 1H-pyrazolo [3, 4-b] pyridine derivatives as salt inducible kinase 2 (SIK2) inhibitors
ARRIEN PHARMACEUTICALS LLC4 citations69
US9206188B2Dec 8, 2015
Substituted pyrrolo[2,3-b]pyridines as ITK and JAK inhibitors
ARRIEN PHARMACEUTICALS LLC5 citations68
US9962382B2May 8, 2018
Substituted 5-(pyrazin-2-yl)-1H-pyrazolo [3, 4-b] pyridine and pyrazolo [3, 4-b] pyridine derivatives as protein kinase inhibitors
ARRIEN PHARMACEUTICALS LLC0 citations48
US9834551B2Dec 5, 2017
Substituted pyrrolo[2,3-b]pyrazines and substituted pyrazolo[3,4-b]pyridines as ITK and JAK kinase inhibitors
ARRIEN PHARMACEUTICALS LLC0 citations48
US9187473B2Nov 17, 2015
Substituted 5-(pyrazin-2-yl)-1H-pyrazolo [3, 4-b] pyridine and pyrazolo [3, 4-b] pyridine derivatives as protein kinase inhibitors
ARRIEN PHARMACEUTICALS LLC0 citations48